Search

everythinglearnresearchcommunity

for

Search:↓

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

A woman with unexplained hair loss was found to have harmless skin tumors and a scarring hair loss condition, but the tumors didn't cause the hair loss.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

A patient with myotonic dystrophy had several autoimmune disorders and thyroid cancer, suggesting a possible link between these conditions.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Many children with alopecia areata also have other autoimmune diseases.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

A woman's hair loss led to discovering she had lupus.

People with autism are more likely to develop alopecia areata than those without autism.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

A girl with severe hair loss saw hair regrowth after using cannabis.

Alopecia areata in elderly people is usually mild and responds well to treatment.